Daniel W. Cramer
YOU?
Author Swipe
View article: Table S3 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Table S3 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes Open
This table shows the associations between epidemiologic risk factors and HGSC subtypes, restricted to White cases and controls
View article: Figure S1 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Figure S1 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes Open
Distribution of subtype proportions by subtype assignment
View article: Table S2 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Table S2 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes Open
This table shows the associations between epidemiologic factors and HGSC subtypes restricted to HGSC cases with probability of subtype assignment >80%.
View article: Data from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Data from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes Open
Background:Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology o…
View article: Table S1 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Table S1 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes Open
This table shows the availability of epidemiologic factors used in the analyses across the different studies.
View article: Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes Open
Background: Ovarian high-grade serous carcinomas (HGSC) comprise four distinct molecular subtypes based on mRNA expression patterns, with differential survival. Understanding risk factor associations is important to elucidate the etiology …
View article: Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium
Diet and survival after a diagnosis of ovarian cancer: a pooled analysis from the Ovarian Cancer Association Consortium Open
View article: Supplemental Table 1 from Estimated ovulatory years prior to menopause and postmenopausal endogenous hormone levels
Supplemental Table 1 from Estimated ovulatory years prior to menopause and postmenopausal endogenous hormone levels Open
Supplemental Table 1: Adjusted geometric mean hormone levels by lifetime ovulatory years quartile among postmenopausal women not using hormone therapy at the time of blood draw in the Nurses' Health Study; excluding hysterectomized women w…
View article: Supplemental Table 1 from Estimated ovulatory years prior to menopause and postmenopausal endogenous hormone levels
Supplemental Table 1 from Estimated ovulatory years prior to menopause and postmenopausal endogenous hormone levels Open
Supplemental Table 1: Adjusted geometric mean hormone levels by lifetime ovulatory years quartile among postmenopausal women not using hormone therapy at the time of blood draw in the Nurses' Health Study; excluding hysterectomized women w…
View article: Data from Estimated ovulatory years prior to menopause and postmenopausal endogenous hormone levels
Data from Estimated ovulatory years prior to menopause and postmenopausal endogenous hormone levels Open
Background Lifetime ovulatory years (LOY) is estimated by the difference between ages at menopause and menarche subtracting time for events interrupting ovulation. We tested whether LOY influences sex-hormone levels in postmenopausal women…
View article: Supplementary Table 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants
Supplementary Table 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants Open
Correlations between anti-CA15.3 index and anti-CA15.3 RLU antibodies in all women and subsets of NHANES
View article: Supplementary Table 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants
Supplementary Table 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants Open
Correlations between anti-CA15.3 index and anti-CA15.3 RLU antibodies in all women and subsets of NHANES
View article: Supplementary Figure 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants
Supplementary Figure 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants Open
Supplementary Figure 1. Distributions of CA15.3 antigens and antibodies.
View article: Supplementary Figure 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants
Supplementary Figure 1 from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants Open
Supplementary Figure 1. Distributions of CA15.3 antigens and antibodies.
View article: Data from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants
Data from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants Open
Background:Cancers of ductal origin often express glycoprotein mucin 1 (MUC1), also known as CA15.3, with higher levels leading to poor prognosis. Conversely, anti-MUC1 antibodies develop in some patients, leading to better prognosis. We s…
View article: Data from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants
Data from Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants Open
Background:Cancers of ductal origin often express glycoprotein mucin 1 (MUC1), also known as CA15.3, with higher levels leading to poor prognosis. Conversely, anti-MUC1 antibodies develop in some patients, leading to better prognosis. We s…
View article: Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease Open
Survival from ovarian cancer depends on the resection status after primary surgery. We performed genome-wide association analyses for resection status of 7705 ovarian cancer patients, including 4954 with high-grade serous carcinoma (HGSOC)…
View article: Incessant ovulation: a review of its importance in predicting cancer risk
Incessant ovulation: a review of its importance in predicting cancer risk Open
Estrous cycles are recurring changes in therian mammals induced by estrogen, progesterone, and other hormones culminating in endometrial proliferation, ovulation, and implantation if fertilization occurred. In women, the estrous cycle is t…
View article: Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels
Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels Open
Supplemental Table 1: Adjusted geometric mean hormone levels by lifetime ovulatory years quartile among postmenopausal women not using hormone therapy at the time of blood draw in the Nurses' Health Study; excluding hysterectomized women w…
View article: Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels
Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels Open
Supplemental Table 1: Adjusted geometric mean hormone levels by lifetime ovulatory years quartile among postmenopausal women not using hormone therapy at the time of blood draw in the Nurses' Health Study; excluding hysterectomized women w…
View article: Data from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels
Data from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels Open
Background:Lifetime ovulatory years (LOY) is estimated by the difference between ages at menopause and menarche subtracting time for events interrupting ovulation. We tested whether LOY influences sex hormone levels in postmenopausal women…
View article: Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis Open
This multicentre analysis indicates that complete surgical cytoreduction to no visible residual disease has the most impact on improved survival in LGSC. This finding could immediately inform and change practice.
View article: Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels
Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels Open
Supplemental Table 1: Adjusted geometric mean hormone levels by lifetime ovulatory years quartile among postmenopausal women not using hormone therapy at the time of blood draw in the Nurses' Health Study; excluding hysterectomized women w…
View article: Data from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels
Data from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels Open
Background:Lifetime ovulatory years (LOY) is estimated by the difference between ages at menopause and menarche subtracting time for events interrupting ovulation. We tested whether LOY influences sex hormone levels in postmenopausal women…
View article: Data from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels
Data from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels Open
Background:Lifetime ovulatory years (LOY) is estimated by the difference between ages at menopause and menarche subtracting time for events interrupting ovulation. We tested whether LOY influences sex hormone levels in postmenopausal women…
View article: Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels
Supplemental Table 1 from Estimated Ovulatory Years Prior to Menopause and Postmenopausal Endogenous Hormone Levels Open
Supplemental Table 1: Adjusted geometric mean hormone levels by lifetime ovulatory years quartile among postmenopausal women not using hormone therapy at the time of blood draw in the Nurses' Health Study; excluding hysterectomized women w…
View article: Data from Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
Data from Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens Open
Establishing a cancer screening biomarker's intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagno…
View article: Supplementary Materials from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Supplementary Materials from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer Open
Supplementary Materials from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
View article: Perspectives on This Article from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Perspectives on This Article from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer Open
Perspectives on This Article from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
View article: Data from Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk
Data from Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk Open
Menstrual pain has been associated with increased ovarian cancer risk, presumably through increased inflammation, which is known to play a critical role in ovarian carcinogenesis. Analgesic medications are frequently used to treat menstrua…